Keyphrases
COVID-19
100%
Bioengineering
100%
High Affinity
58%
Amyloid-like
56%
Nanoparticles
50%
Nanofibrils
50%
Receptor-binding Domain
35%
Angiotensin-converting Enzyme 2 Receptor
31%
Virus-like
22%
2 Receptor
18%
Spike Protein
16%
COVID-19 Pandemic
14%
Host Cell
14%
LCB1
12%
Sup35
12%
Protein Receptor
8%
Receptor-ligand Interaction
8%
Primary Health
8%
IC50 Value
8%
Biocompatibility
8%
Protein-based
8%
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
8%
Particle Fusion
8%
Miniprotein
8%
Nanotechnology
8%
Angiotensin-converting Enzyme 2 (ACE2)
8%
Health Anxiety
8%
Multivalent
8%
Viral Entry
8%
Nanostructures
8%
Virus Neutralization
8%
Self-assembly Strategy
8%
Novel Protein
8%
Oligomeric Nanoparticles
8%
Viral Diagnostics
6%
Viral Sampling
6%
Primary Entry
6%
Fusion Protein
6%
Viral Spread
6%
Antiviral Activity
6%
Yeast Prion
6%
Functional Nanomaterials
6%
Wet Environment
6%
Genetic Engineering
6%
Spontaneous Self-assembly
6%
Therapeutic Antibody
6%
Virus
6%
Well-dispersed
6%
Diagnostic Tool
6%
Reaction Conditions
6%
Pharmacology, Toxicology and Pharmaceutical Science
SARS Coronavirus
100%
Amyloid Protein
68%
Receptor
60%
Nanoparticle
50%
Angiotensin Converting Enzyme 2
27%
Virus Like Agent
20%
Vitronectin
14%
Nanomaterial
13%
Disease
13%
Coronavirinae
13%
Infection
7%
IC50
7%
Antiviral Activity
6%
Chimeric Protein
6%
Prion Protein
6%
Biochemistry, Genetics and Molecular Biology
SARS Coronavirus
100%
Amyloid Protein
68%
Receptor Binding
33%
Binding Domain
33%
Angiotensin-Converting Enzyme 2
27%
Virus-Like Particle
20%
Vitronectin
14%
Coronavirinae
13%
Spike
7%
Virus Entry
7%
IC50
7%
Blood Plasma
7%
Virus Neutralization
7%
Therapeutic Antibodies
6%
Prion Protein
6%
Antiviral Activity
6%
Chimeric Protein
6%